desmoid tumor

Search with Google Search with Bing
Information
Disease name
desmoid tumor
Disease ID
DOID:0080366
Description
"A connective tissue benign neoplasm that occur most often in the abdomen, arms and legs." [url:https\://ghr.nlm.nih.gov/condition/desmoid-tumor, url:https\://rarediseases.org/rare-diseases/desmoid-tumor/, url:https\://www.ncbi.nlm.nih.gov/pubmed/28489620]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03785964 Active, not recruiting Phase 3 Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) April 17, 2019 December 31, 2024
NCT02076906 Active, not recruiting Phase 1 MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors April 2014 November 24, 2024
NCT04871282 Active, not recruiting Phase 2/Phase 3 A Study of AL102 in Patients With Progressing Desmoid Tumors March 30, 2021 February 25, 2025
NCT05041036 Available Individual Patient Compassionate Use of Nirogacestat
NCT00287846 Completed Phase 1/Phase 2 Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis September 2004 June 2010
NCT00474994 Completed Phase 2 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas April 2007 November 2010
NCT01137916 Completed Phase 2 Study to Evaluate Imatinib in Desmoid Tumors June 2010 December 2016
NCT01265030 Completed Phase 1/Phase 2 A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis February 2014 December 22, 2021
NCT01286662 Completed A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome January 1978 December 2010
NCT01567046 Completed Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas May 2016 May 2016
NCT03190174 Completed Phase 1/Phase 2 Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers August 24, 2017 December 2, 2021
NCT03459469 Completed Phase 1 Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 July 15, 2018 May 1, 2022
NCT03802084 Completed Phase 1/Phase 2 A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor April 15, 2019 March 26, 2024
NCT04289077 Completed Quality of Life of Patients With Desmoid-type Fibromatosis August 6, 2020 February 1, 2021
NCT00002595 Completed Phase 2 Toremifene in Treating Patients With Desmoid Tumors July 1991 September 2010
NCT00003019 Completed Phase 2 Vinblastine and Methotrexate in Treating Children With Desmoid Tumors August 1997 September 2006
NCT00030680 Completed Phase 2 Radiation Therapy in Treating Patients With Aggressive Fibromatoses November 2001 March 2012
NCT00068419 Completed Phase 2 Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor February 2004 April 26, 2010
NCT06195085 Completed CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors July 1, 2013 July 1, 2023
NCT02955446 No longer available Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
NCT06355921 Not yet recruiting N/A A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors April 1, 2024 May 1, 2028
NCT05561036 Recruiting Phase 3 A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor September 29, 2020 March 1, 2023
NCT05949099 Recruiting Phase 2 Study of Cryoablation and Nirogacestat for Desmoid Tumor August 15, 2023 February 1, 2028
NCT06081400 Recruiting N/A Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting March 4, 2024 June 2029
NCT06258421 Recruiting Burden of Disease and Living Situation in Desmoid Patients October 1, 2023 December 2024
Disase is a (Disease Ontology)
DOID:0060123
OrphaNumber from OrphaNet (Orphanet)
873